Dupilumab and atopic march; Reduction of incident allergic events or Clinical control?. Revista Alergia México, [S. l.], v. 71, n. 3, p. 216–217, 2024. DOI: 10.29262/ram.v71i3.1302. Disponível em: https://revistaalergia.mx/ojs/index.php/ram/article/view/1302. Acesso em: 28 apr. 2025.